This article is intended for licensed medical providers and does not constitute medical, clinical, or legal advice. It is provided for educational and informational purposes to support providers considering or expanding an erectile dysfunction treatment offering as part of a broader men’s health service line.
Erectile dysfunction (ED) is one of the most common concerns men raise with their providers, and one of the least often addressed proactively. Many men wait years before bringing it up, and many practices, in turn, have not built a structured way to have that conversation, screen for underlying causes, or offer a range of treatment categories. For med spas, primary care practices, and men’s health clinics already offering Testosterone Replacement Therapy (TRT), adding an ED-focused offering is often a natural next step.
Why ED Belongs in Your Men’s Health Conversation
Patients who seek out TRT are frequently the same patients experiencing symptoms of erectile dysfunction, since the two concerns often share overlapping physiological and lifestyle contributors. Practices that already have an established men’s health service line, and a patient base comfortable discussing hormone-related concerns, are often well positioned to extend that same comfort level to ED.
Public awareness of ED treatment options has grown substantially in recent years, driven by direct-to-consumer telehealth marketing and broader cultural openness about men’s health topics. Patients are increasingly aware that options exist beyond what they may have tried in the past, and many are actively looking for a provider relationship rather than a one-off online transaction.
Understanding Erectile Dysfunction: An Educational Overview
Erectile dysfunction refers to the persistent inability to achieve or maintain an erection sufficient for sexual activity. The literature discusses a wide range of contributing factors, including cardiovascular health, hormonal balance, psychological factors, medication side effects, and lifestyle considerations such as sleep, stress, and physical activity.
Because ED can also be an early indicator of broader cardiovascular or metabolic concerns, providers often find that an ED conversation opens the door to a more comprehensive men’s health evaluation. This makes ED a natural entry point for practices building out a full men’s health service line, rather than a narrow, standalone offering.
The Treatment Landscape for Erectile Dysfunction
Providers and patients today have access to both FDA-approved pharmaceutical products and compounded formulations for ED. Understanding the distinction between these categories, and being prepared to explain it clearly to patients, is an important part of building a credible ED service line.
FDA-Approved Oral Medications
A range of FDA-approved oral medications for ED is available and well established in clinical practice. Providers weighing FDA-approved options against compounded alternatives for a given patient are encouraged to consider the full clinical picture, and questions about how a specific product fits a specific patient’s treatment plan are a determination for the treating provider in accordance with the applicable standard of care.
Compounded Formulations
Compounded sildenafil, compounded tadalafil, and compounded injectable formulations such as trimix are not FDA-approved. They have not been evaluated by the FDA for safety, effectiveness, or quality, and they are not the same as or equivalent to any FDA-approved product. Compounded formulations may only be dispensed pursuant to a valid, patient-specific prescription written by a licensed prescriber, and filled through a properly licensed pharmacy, in accordance with applicable law.
Some patients are drawn to compounded formulations because of flexibility in strength, formulation, or delivery method that may not be available in a manufactured product, including topical or injectable options for patients who have not had success with oral therapy. Providers exploring these formulations as part of a men’s health offering are encouraged to work directly with a properly licensed compounding pharmacy and to consult current guidelines from relevant professional organizations regarding patient selection and counseling.
Building an Educational Framework for the ED Conversation
Because ED carries more stigma for many patients than other men’s health topics, practices that succeed in this space tend to invest specifically in how the conversation is introduced and normalized. Common elements of that framework include the following, offered here as categories for awareness rather than a required protocol:
- A brief, low-pressure way to raise the topic during a routine visit or intake
- A general overview of the range of contributing factors patients may want to discuss with their provider
- A description of the categories of treatment available for further discussion, including lifestyle, oral, and compounded options
- An explanation of the distinction between FDA-approved and compounded products
- A clear invitation for the patient to ask questions and discuss their individual history and goals with the provider
Each of these categories is intentionally general. The specific content of any individual patient conversation, and the resulting treatment decisions, remain the responsibility of the treating provider.
Front-office and intake staff often play a larger role in ED conversations than practices initially expect, simply by making the topic feel like a routine part of the men’s health intake rather than something a patient has to bring up unprompted. Preparing this team with the same general vocabulary used by providers helps keep the patient experience consistent from the first phone call through the clinical visit.
The Provider’s Role in Individualized Care
As with any men’s health concern, ED presentations vary widely across patients, and the literature emphasizes an individualized approach over a one-size-fits-all protocol. Decisions about which category of treatment to explore, how a patient’s history and goals factor into that conversation, and how any therapy is monitored over time are clinical determinations that rest with the treating provider.
Providers building out this offering often find it useful to establish an internal process for how these conversations are documented and how follow-up is scheduled, consistent with their own clinical judgment and applicable professional guidelines. The specific parameters and timing of any follow-up are clinical determinations for the treating provider.
Regulatory and Legal Considerations
The regulatory environment surrounding compounded medications, including those used in ED treatment, continues to evolve at both the federal and state level. Providers building or expanding an ED offering are encouraged to consult a qualified healthcare regulatory attorney regarding licensing, scope-of-practice, and pharmacy sourcing questions specific to their state and practice setting.
Staffing and supervision arrangements for a men’s health program are governed by state-specific scope-of-practice rules that vary by state, and providers should confirm current requirements with appropriate legal counsel before finalizing a staffing model. Because guidance in this area continues to change, providers are encouraged to monitor applicable FDA and state pharmacy board guidance on an ongoing basis.
Expanding Your Practice’s Men’s Health Services
For practices already offering TRT, adding an ED-focused offering is often a natural extension rather than an entirely new service line. It allows a practice to serve patients who may already be comfortable discussing hormone-related concerns, while building on the intake, consultation, and follow-up infrastructure the practice has likely already established.
Practices considering this expansion often start by reviewing their existing TRT patient base for overlap, since many patients already being evaluated for hormone-related concerns may also be navigating ED. This can make an ED offering a low-friction addition that rounds out an existing men’s health program rather than requiring a separate marketing or intake effort.
As with any new or expanded service line, practices are encouraged to evaluate their own clinical capacity, staffing, and compliance processes, and to consult qualified legal and clinical advisors as they build out this area of care.
Sourcing Through NMR Meds
NMR Meds is a licensed distributor of pharmaceutical and wellness products to licensed healthcare providers. NMR Meds does not provide medical, clinical, or legal advice, and does not recommend, direct, or prescribe any course of treatment. Providers interested in learning more about product availability are encouraged to reach out to their NMR Meds representative to discuss their practice’s specific needs.
Related Resources
For background on the related men’s health service this article clusters under, see Testosterone Replacement Therapy for Men: What Patients Ask and What Providers Need to Know on nmrmeds.com.
For additional provider- and patient-facing background on ED treatment options, see the National Institute of Diabetes and Digestive and Kidney Diseases’ overview, Treatment for Erectile Dysfunction.
MEDICAL & LEGAL DISCLAIMER
The information contained in this article is intended for licensed healthcare providers and qualified medical professionals only. It is provided for general informational and educational purposes and does not constitute medical advice, clinical guidance, or a substitute for the independent professional judgment of a licensed physician or other qualified healthcare provider.
Nothing in this article should be construed as a recommendation to diagnose, treat, cure, or prevent any disease or medical condition, nor as guidance on prescribing or administering any pharmaceutical compound to any specific patient. All clinical decisions regarding patient eligibility, dosing, monitoring, and treatment should be made by a licensed healthcare provider based on the individual patient’s clinical presentation, medical history, and applicable standard of care.
COMPOUNDED MEDICATION DISCLOSURE:
Compounded medications, including compounded sildenafil, compounded tadalafil, and compounded injectable formulations such as trimix, are not FDA-approved drugs and have not been evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. Compounded drugs are not generic versions of, and are not the same as or equivalent to, FDA-approved products such as Viagra® or Cialis®. Compounded sildenafil, tadalafil, and injectable formulations may only be dispensed pursuant to a valid, patient-specific prescription issued by a licensed prescriber. Nothing in this article constitutes a claim that any compounded product is clinically proven, has been evaluated in clinical trials, or produces the same results as any FDA-approved drug.
The regulatory landscape governing compounded medications is subject to change. Information provided in this article reflects publicly available guidance as of the publication date and may not reflect the most current regulatory requirements. Readers are strongly encouraged to consult with a qualified healthcare regulatory attorney and to monitor updates from the U.S. Food and Drug Administration (FDA) and applicable state pharmacy boards before initiating or modifying any compounding or dispensing program.
National Medical Resources, Inc. (NMR Meds) is a distributor of medical and wellness products to licensed healthcare providers. NMR Meds does not provide medical advice, clinical consultation, or legal guidance. References to specific products, dosing schedules, or clinical protocols in this article are for informational and educational purposes only and do not constitute an endorsement of any specific treatment approach.
© 2026 National Medical Resources, Inc. All rights reserved. This content is intended for licensed healthcare professionals and may not be reproduced or redistributed without written permission.